Table 2. Patients characteristics.

Feature	Overall
Female sex, n(%)	23 (33%)
Age years, mean (range)	57 (35–69)
Cirrhosis, n(%)	51 (74%)
eGFR, mean ml/min	93,2
HCV 1b genotype, n(%)	57 (83%)
HCV-RNA>600.000 IU/ml, n(%)	42 (61%)
Hb g/dL, mean (range)	15,1 (10,8–18,0)
Male	15,6 (12,0–18,0)
Female	14,2 (10,8–15,9)
Previous treatment status, n(%)
Naive	9 (13%)
Relapse	26 (38%)
Partial Response	10 (14%)
Null response	22 (32%)
Breakthrough	2 (3%)
Grade of ITPA deficiency, n(%)
No deficiency	48 (70%)
Mild deficiency	12 (17%)
Moderate deficiency	9 (13%)